Advertisement
QIAGEN Ingenuity
QIAGEN Ingenuity

The Scientist

» pharmaceuticals

Most Recent

image: Taking Shots at Ebola

Taking Shots at Ebola

By | November 5, 2014

With an infusion of public and private resources and accelerated regulatory processes, a handful of companies are racing to develop a vaccine to curb the Ebola epidemic.

4 Comments

image: Report: Sales for Antibiotics on Farms Rose

Report: Sales for Antibiotics on Farms Rose

By | October 6, 2014

Amid concerns that the use of antibiotics may contribute to drug resistance, sales for use in livestock rose in recent years.

0 Comments

image: AbbVie Buys Shire for $54 Billion

AbbVie Buys Shire for $54 Billion

By | July 21, 2014

The massive pharma deal will create one of the 50 largest companies in the world, and will move AbbVie’s corporate tax headquarters from North Chicago to the U.K.

0 Comments

image: Welcome Back, Pharmalot

Welcome Back, Pharmalot

By | June 4, 2014

The Wall Street Journal revives the popular blog covering pharmaceutical and biotech industry news.

0 Comments

image: Novartis and Glaxo Agree to Big Deal

Novartis and Glaxo Agree to Big Deal

By | April 22, 2014

The pharmaceutical companies announce a suite of asset swaps that drove up share prices and will reshape both.

2 Comments

image: J&J to Share Trial Data

J&J to Share Trial Data

By | January 31, 2014

The pharmaceutical giant teams up with Yale University to make raw clinical data available to researchers.

0 Comments

image: UK Government Laments Tamiflu Secrets

UK Government Laments Tamiflu Secrets

By | January 6, 2014

A parliamentary committee says drugmakers have not disclosed enough data on the anti-influenza medicine.

0 Comments

image: Goodbye, Pharmalot

Goodbye, Pharmalot

By | January 2, 2014

The popular blog covering pharmaceutical and biotech industry news has been shuttered.  

2 Comments

image: Company Size Won’t Predict Success

Company Size Won’t Predict Success

By | October 23, 2013

New analysis finds that the size of a company is not tied to getting a drug to market.

0 Comments

image: Clinical Silence

Clinical Silence

By | October 10, 2013

A study has shown that less than half of the outcomes of some clinical trials are publicly available.

0 Comments

Advertisement

Popular Now

  1. First Data from Anti-Aging Gene Therapy
  2. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  3. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  4. Locating Language within the Brain
Advertisement
Advertisement
RayBioTech